Summary
The video examines the Ebola outbreak in DRC and Uganda amid Trump's America First health strategy, which dismantled USAID and shifted to bilateral deals requiring more domestic funding. Africa CDC warns of a $518 million funding gap, while vaccine developers IAVI, Moderna, and Oxford accelerate trials. Meanwhile, some African nations push back on U.S. health agreements, with Zambia's critical minerals becoming a sticking point.
- Ebola outbreak in DRC and Uganda highlights U.S. foreign aid overhaul under Trump's 'America First' policy.
- USAID dismantled, replaced by bilateral health agreements demanding greater country ownership and domestic financing.
- Africa CDC's Jean Kaseya says border closures are not a solution; $518 million needed, less than half raised.
- Vaccine candidates from IAVI, Moderna, and University of Oxford backed by $60 million from CEPI, clinical trials expected by end of 2025.
- Mozambique case illustrates risks of funding gaps for HIV, malaria, TB programs as countries adapt to new aid model.
- Zambia and Zimbabwe reject U.S. health deals over demands for preferential access to their critical minerals.
- Kenya faces legal challenges to its signed health agreement, raising sovereignty and data-sharing concerns.
- Africa CDC pushes for local vaccine manufacturing capacity, but funding cuts create obstacles.